Ajay Aggarwal, M.D.

13% more Medicare Part D claims than the average adult reconstructive orthopaedic surgery physician in 2024

654 Medicare Part D claims for 199 beneficiaries, against an average of 579 among the 1,112 providers of this specialty who prescribed in Part D. Brand-name drugs were 0% of claims.

Most prescribed

1. Meloxicam288 claims
2. Amoxicillin68 claims
3. Celecoxib47 claims
4. Cyclobenzaprine Hcl45 claims
5. Cephalexin33 claims
6. Clindamycin Hcl31 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 100 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $7,364.86

16 payments; by number, the most common kind was food and beverage; the largest payer was Stryker Corporation. The 1,060 providers of this specialty with any payment received $68,015.27 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

1. The Curators OF The University OF MissouriColumbia, MO

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).